Tyme Technologies, Inc. (TYME) financial statements (2020 and earlier)

Company profile

Business Address 17 STATE STREET
NEW YORK, NY 10004
State of Incorp. DE
Fiscal Year End March 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
TTM
3/31/2019
3/31/2018
3/31/2017
12/31/2015
11/30/2014
11/30/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments111429104  
Cash and cash equivalents111429104  
Prepaid expense 00    
Other undisclosed current assets12200  
Total current assets:121631114  
Noncurrent Assets
Operating lease, right-of-use asset0
Property, plant and equipment00000  
Other undisclosed noncurrent assets11     
Total noncurrent assets:21000  
TOTAL ASSETS:141831114  
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:2210000
Accounts payable00000  
Accrued liabilities00000  
Employee-related liabilities111    
Other undisclosed accounts payable and accrued liabilities     00
Debt010    
Derivative instruments and hedges, liabilities   0   
Due to related parties     0 
Other undisclosed current liabilities44331 0
Total current liabilities:5653100
Noncurrent Liabilities
Long-term debt and lease obligation0      
Operating lease, liability0
Other undisclosed noncurrent liabilities62     
Total noncurrent liabilities:62     
Total liabilities:11853100
Stockholders' equity
Stockholders' equity attributable to parent2102673(0)(0)
Common stock0000000
Common stock, share subscribed but unissued, subscriptions receivable   (0)   
Common stock, value, subscriptions   0  
Additional paid in capital1049579411900
Accumulated deficit(102)(86)(53)(34)(16)(0)(0)
Total stockholders' equity:2102673(0)(0)
TOTAL LIABILITIES AND EQUITY:141831114  

Income statement (P&L) ($ in millions)

12/31/2019
TTM
3/31/2019
3/31/2018
3/31/2017
12/31/2015
11/30/2014
11/30/2013
Operating expenses(29)(32)(19)(15)(9)(0)(0)
Operating loss:(29)(32)(19)(15)(9)(0)(0)
Nonoperating income300 0  
Other nonoperating income3      
Interest and debt expense(0)   (4)  
Other undisclosed income from continuing operations before equity method investments, income taxes0      
Loss from continuing operations before equity method investments, income taxes:(26)(32)(19)(15)(12)(0)(0)
Other undisclosed loss from continuing operations before income taxes(1)(1)     
Loss from continuing operations before income taxes:(28)(33)(19)(15)(12)(0)(0)
Income tax benefit     0 
Loss before gain (loss) on sale of properties:(28)(33)(19)(15)(12)(0)(0)
Other undisclosed net income0      
Net loss:(28)(33)(19)(15)(12)(0)(0)
Other undisclosed net income (loss) attributable to parent0    (0) 
Net loss available to common stockholders, diluted:(27)(33)(19)(15)(12)(0)(0)

Comprehensive Income ($ in millions)

12/31/2019
TTM
3/31/2019
3/31/2018
3/31/2017
12/31/2015
11/30/2014
11/30/2013
Net loss:(28)(33)(19)(15)(12)(0)(0)
Comprehensive loss, net of tax, attributable to parent:(28)(33)(19)(15)(12)(0)(0)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: